Tanabe Pharma Corp - Strategic SWOT Analysis Review
Description
Tanabe Pharma Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
Tanabe Pharma Corp (Tanabe), formerly Mitsubishi Tanabe Pharma Corp, a subsidiary of Mitsubishi Chemical Holdings Corp, identifies, develops, manufactures, procures, and commercializes ethical drugs and over-the-counter (OTC) pharmaceutical products. The company develops ethical drugs for autoimmune diseases, diabetes, kidney diseases, central nervous system (CNS) disorders, and others. It also develops vaccines for preventing various infectious diseases. Tanabe also offers major products for skin conditions and digestive medicines. The company markets its products to wholesalers, hospitals, clinics, and drugstores. It has subsidiaries in Asia, Europe, and North America. Tanabe is headquartered in Osaka, Japan.
Tanabe Pharma Corp Key Recent Developments
Feb 02,2026: Tanabe Pharma : Announcement of Organizational Changes and Personnel Changes
Dec 25,2025: Mitsubishi Tanabe : Announcement of Personnel Changes
Dec 01,2025: Tanabe Pharma : Tokyo Head Office to be Relocated
Nov 25,2025: GV20 Therapeutics Announces Achievement of Milestone Under Antibody-Drug Conjugate Collaboration With Mitsubishi Tanabe Pharma Corporation
Reasons to Buy
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
Tanabe Pharma Corp (Tanabe), formerly Mitsubishi Tanabe Pharma Corp, a subsidiary of Mitsubishi Chemical Holdings Corp, identifies, develops, manufactures, procures, and commercializes ethical drugs and over-the-counter (OTC) pharmaceutical products. The company develops ethical drugs for autoimmune diseases, diabetes, kidney diseases, central nervous system (CNS) disorders, and others. It also develops vaccines for preventing various infectious diseases. Tanabe also offers major products for skin conditions and digestive medicines. The company markets its products to wholesalers, hospitals, clinics, and drugstores. It has subsidiaries in Asia, Europe, and North America. Tanabe is headquartered in Osaka, Japan.
Tanabe Pharma Corp Key Recent Developments
Feb 02,2026: Tanabe Pharma : Announcement of Organizational Changes and Personnel Changes
Dec 25,2025: Mitsubishi Tanabe : Announcement of Personnel Changes
Dec 01,2025: Tanabe Pharma : Tokyo Head Office to be Relocated
Nov 25,2025: GV20 Therapeutics Announces Achievement of Milestone Under Antibody-Drug Conjugate Collaboration With Mitsubishi Tanabe Pharma Corporation
Reasons to Buy
- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Table of Contents
45 Pages
- Section 1 - About the Company
- Tanabe Pharma Corp - Key Facts
- Tanabe Pharma Corp - Key Employees
- Tanabe Pharma Corp - Key Employee Biographies
- Tanabe Pharma Corp - Major Products and Services
- Tanabe Pharma Corp - History
- Tanabe Pharma Corp - Company Statement
- Tanabe Pharma Corp - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Joint Venture
- Section 2 – Company Analysis
- Company Overview
- Tanabe Pharma Corp - Business Description
- R&D Overview
- Tanabe Pharma Corp - SWOT Analysis
- SWOT Analysis - Overview
- Tanabe Pharma Corp - Strengths
- Tanabe Pharma Corp - Weaknesses
- Tanabe Pharma Corp - Opportunities
- Tanabe Pharma Corp - Threats
- Tanabe Pharma Corp - Key Competitors
- Section 3 – Company’s Lifesciences Financial Deals and Alliances
- Tanabe Pharma Corp, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
- Tanabe Pharma Corp, Pharmaceuticals & Healthcare, Deals By Type, 2020 to YTD 2026
- Tanabe Pharma Corp, Recent Deals Summary
- Section 4 – Company’s Recent Developments
- Feb 02, 2026: Tanabe Pharma : Announcement of Organizational Changes and Personnel Changes
- Dec 25, 2025: Mitsubishi Tanabe : Announcement of Personnel Changes
- Dec 01, 2025: Tanabe Pharma : Tokyo Head Office to be Relocated
- Nov 25, 2025: GV20 Therapeutics Announces Achievement of Milestone Under Antibody-Drug Conjugate Collaboration With Mitsubishi Tanabe Pharma Corporation
- Oct 20, 2025: Mitsubishi Tanabe Pharma Announces Personnel Changes
- Sep 22, 2025: Mitsubishi Tanabe Pharma : Announcement of Organizational Changes and Personnel Change
- Aug 29, 2025: Mitsubishi Tanabe Pharma : Change in Representative Director, New Executive Team and Management Structure
- Jul 10, 2025: Mitsubishi Tanabe Pharma Initiates Joint Research in Japan With Veneno Technologies and Alpha Fusion on Development of Targeted Alpha Therapy
- May 20, 2025: Mitsubishi Tanabe : Appointment of Directors
- Jan 10, 2025: Synaffix secures ADC deals with Boehringer and Mitsubishi Tanabe
- Section 5 – Appendix
- Methodology
- About GlobalData
- Contact Us
- Disclaimer
- List of Tables
- Tanabe Pharma Corp, Key Facts
- Tanabe Pharma Corp, Key Employees
- Tanabe Pharma Corp, Key Employee Biographies
- Tanabe Pharma Corp, Major Products and Services
- Tanabe Pharma Corp, History
- Tanabe Pharma Corp, Other Locations
- Tanabe Pharma Corp, Subsidiaries
- Tanabe Pharma Corp, Joint Venture
- Tanabe Pharma Corp, Key Competitors
- Tanabe Pharma Corp, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
- Tanabe Pharma Corp, Pharmaceuticals & Healthcare, Deals By Type, 2020 to YTD 2026
- Tanabe Pharma Corp, Recent Deals Summary
- List of Figures
- Tanabe Pharma Corp, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
- Tanabe Pharma Corp, Pharmaceuticals & Healthcare, Deals by Type, 2020 to YTD 2026
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

